These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15053337)

  • 21. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.
    Indraccolo S; Mion M; Zamarchi R; Veronesi A; Veronese ML; Panozzo M; Betterle C; Barelli A; Borri A; Amadori A
    J Clin Immunol; 1993 Nov; 13(6):381-8. PubMed ID: 7507125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Premature ageing of the immune system relates to increased anti-lymphocyte antibodies (ALA) after an immunization in HIV-1-infected and kidney-transplanted patients.
    Cagigi A; Rinaldi S; Santilli V; Mora N; C Manno E; Cotugno N; Zangari P; Aquilani A; Guzzo I; Dello Strologo L; Rossi P; Palma P
    Clin Exp Immunol; 2013 Nov; 174(2):274-80. PubMed ID: 23841754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease.
    Moir S; Fauci AS
    J Allergy Clin Immunol; 2008 Jul; 122(1):12-9; quiz 20-1. PubMed ID: 18547629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy.
    Fondere JM; Huguet MF; Yssel H; Baillat V; Reynes J; van de Perre P; Vendrell JP
    AIDS; 2003 Nov; 17(16):2323-30. PubMed ID: 14571183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals.
    Montezuma-Rusca JM; Moir S; Kardava L; Buckner CM; Louie A; Kim LJ; Santich BH; Wang W; Fankuchen OR; Diaz G; Daub JR; Rosenzweig SD; Chun TW; Li Y; Braylan RC; Calvo KR; Fauci AS
    J Immunol; 2015 Mar; 194(6):2561-8. PubMed ID: 25681347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-cell subset alterations and correlated factors in HIV-1 infection.
    Pensieroso S; Galli L; Nozza S; Ruffin N; Castagna A; Tambussi G; Hejdeman B; Misciagna D; Riva A; Malnati M; Chiodi F; Scarlatti G
    AIDS; 2013 May; 27(8):1209-17. PubMed ID: 23343911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV.
    Bussmann BM; Reiche S; Bieniek B; Krznaric I; Ackermann F; Jassoy C
    Virology; 2010 Feb; 397(1):7-13. PubMed ID: 19962720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of HIV infection and highly active antiretroviral therapy (HAART) on B cell subpopulations in children.
    Singh R; Mukherjee A; Singla M; Vajpayee M; Negi N; Kabra SK; Lodha R; Das BK
    J Med Virol; 2018 Jul; 90(7):1222-1231. PubMed ID: 29575050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection.
    Levesque MC; Moody MA; Hwang KK; Marshall DJ; Whitesides JF; Amos JD; Gurley TC; Allgood S; Haynes BB; Vandergrift NA; Plonk S; Parker DC; Cohen MS; Tomaras GD; Goepfert PA; Shaw GM; Schmitz JE; Eron JJ; Shaheen NJ; Hicks CB; Liao HX; Markowitz M; Kelsoe G; Margolis DM; Haynes BF
    PLoS Med; 2009 Jul; 6(7):e1000107. PubMed ID: 19582166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cells in HIV pathogenesis.
    de Bree GJ; Lynch RM
    Curr Opin Infect Dis; 2016 Feb; 29(1):23-30. PubMed ID: 26658653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells.
    Macchia D; Almerigogna F; Parronchi P; Ravina A; Maggi E; Romagnani S
    Nature; 1993 Jun; 363(6428):464-6. PubMed ID: 7684824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in the immunopathology of HIV infection].
    Alcamí J
    Enferm Infecc Microbiol Clin; 2004 Oct; 22(8):486-96. PubMed ID: 15482691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-mediated B-lymphocyte activation and lymphomagenesis.
    Monroe JG; Silberstein LE
    J Clin Immunol; 1995 Mar; 15(2):61-8. PubMed ID: 7559909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune signatures for HIV-1 and HIV-2 induced CD4
    Salwe S; Singh A; Padwal V; Velhal S; Nagar V; Patil P; Deshpande A; Patel V
    BMC Infect Dis; 2019 Feb; 19(1):135. PubMed ID: 30744575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B cells in HIV infection and disease.
    Moir S; Fauci AS
    Nat Rev Immunol; 2009 Apr; 9(4):235-45. PubMed ID: 19319142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
    Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
    J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.
    Younas M; Psomas C; Reynes J; Corbeau P
    HIV Med; 2016 Feb; 17(2):89-105. PubMed ID: 26452565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.